Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Signal transducer and activator of transcription 3"" wg kryterium: Temat


Tytuł :
Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells.
Autorzy :
Wang X; Department of Medical Oncology, Shanghai Tenths People's Hospital, School of Medicine, Tongji University, Shanghai, China.; Department of Radio therapy, Hwa Mei Hospital, University of Chinese Academy of Science, Ningbo, Zhejiang, China.; Department of Oncology, Dermatology Hospital, Tongji University, Shanghai, China.; Tongji University Cancer Center, Shanghai, China.
Shao X; Department of Medical Oncology, Shanghai Tenths People's Hospital, School of Medicine, Tongji University, Shanghai, China.; Department of Oncology, Dermatology Hospital, Tongji University, Shanghai, China.; Tongji University Cancer Center, Shanghai, China.
Gu L; Department of Medical Oncology, Shanghai Tenths People's Hospital, School of Medicine, Tongji University, Shanghai, China.; Department of Oncology, Dermatology Hospital, Tongji University, Shanghai, China.; Tongji University Cancer Center, Shanghai, China.
Jiang K; Institute of Cancer Stem Cell, Dalian Medical University Cancer Center, Dalian, China.
Wang S; Department of Medical Oncology, Shanghai Tenths People's Hospital, School of Medicine, Tongji University, Shanghai, China.; Department of Oncology, Dermatology Hospital, Tongji University, Shanghai, China.; Tongji University Cancer Center, Shanghai, China.
Chen J; Department of Medical Oncology, Shanghai Tenths People's Hospital, School of Medicine, Tongji University, Shanghai, China.; Department of Oncology, Dermatology Hospital, Tongji University, Shanghai, China.; Tongji University Cancer Center, Shanghai, China.
Fang J; Department of Medical Oncology, Shanghai Tenths People's Hospital, School of Medicine, Tongji University, Shanghai, China.; Department of Oncology, Dermatology Hospital, Tongji University, Shanghai, China.; Tongji University Cancer Center, Shanghai, China.
Guo X; Department of Medical Oncology, Shanghai Tenths People's Hospital, School of Medicine, Tongji University, Shanghai, China.; Department of Oncology, Dermatology Hospital, Tongji University, Shanghai, China.; Tongji University Cancer Center, Shanghai, China.
Yuan M; Department of Medical Oncology, Shanghai Tenths People's Hospital, School of Medicine, Tongji University, Shanghai, China.; Department of Oncology, Dermatology Hospital, Tongji University, Shanghai, China.; Tongji University Cancer Center, Shanghai, China.
Shi J; Department of Neurosurgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.
Ding C; Department of Avian Infectious Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Science, Shanghai, China.
Meng S; Institute of Cancer Stem Cell, Dalian Medical University Cancer Center, Dalian, China.
Xu Q; Department of Medical Oncology, Shanghai Tenths People's Hospital, School of Medicine, Tongji University, Shanghai, China.; Department of Oncology, Dermatology Hospital, Tongji University, Shanghai, China.; Tongji University Cancer Center, Shanghai, China.
Pokaż więcej
Źródło :
Journal of cellular and molecular medicine [J Cell Mol Med] 2020 Apr; Vol. 24 (7), pp. 4286-4297. Date of Electronic Publication: 2020 Feb 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Targeting the PI3K/STAT3 axis modulates age-related differences in macrophage phenotype in rats with myocardial infarction.
Autorzy :
Lin CC; Department of Medical Research, Chi-Mei Medical Center, Tainan, Taiwan.
Chen SY; Cardiovascular Institute, An Nan Hospital, China Medical University, Tainan, Taiwan.
Lien HY; Department of pharmacy, Kaohsiung Veterans general hospital Tainan branch, Tainan, Taiwan.
Lin SZ; Bioinnovation Center, Tzu Chi foundation, Department of Neurosurgery, Buddhist Tzu Chi General Hospital, Tzu Chi University, Yunlin, Taiwan.
Lee TM; Cardiovascular Institute, An Nan Hospital, Tainan, Taiwan.; Department of Medicine, China Medical University, Taichung, Taiwan.
Pokaż więcej
Źródło :
Journal of cellular and molecular medicine [J Cell Mol Med] 2019 Sep; Vol. 23 (9), pp. 6378-6392. Date of Electronic Publication: 2019 Jul 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Macrophages/*metabolism
Myocardial Infarction/*metabolism
Myocardium/*metabolism
Phosphatidylinositol 3-Kinase/*metabolism
STAT3 Transcription Factor/*metabolism
Animals ; Fibrosis/drug therapy ; Fibrosis/metabolism ; Interleukin-10/metabolism ; Macrophages/drug effects ; Male ; Myocardial Infarction/drug therapy ; Myocytes, Cardiac/drug effects ; Myocytes, Cardiac/metabolism ; Myofibroblasts/drug effects ; Myofibroblasts/metabolism ; Phenotype ; Phosphorylation/drug effects ; Phosphorylation/physiology ; Phthalic Anhydrides/pharmacology ; Rats ; Rats, Wistar ; Signal Transduction/drug effects ; Signal Transduction/physiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies